El código SA/NC 30021091 se considera fuera del ámbito para la preparación EUDR.
Haemoglobin, blood globulins and serum globulins(2012-2016);Haemoglobin, blood globulins and serum globulins(2002-2011);Haemoglobin, blood globulins and serum globulins(1988-2001) El motor de ámbito indexado devuelve Out of scope para este código. No Annex I scope match was found for this indexed CN code.
Por qué esta página de referencia da esa respuesta.
- Descripción del código
- Haemoglobin, blood globulins and serum globulins(2012-2016);Haemoglobin, blood globulins and serum globulins(2002-2011);Haemoglobin, blood globulins and serum globulins(1988-2001)
- Base en el anexo I
- Sin entrada directa en el anexo I
- Base de la fuente
- Regulation (EU) 2023/1115 Annex I and CN 2026 index
Filas superiores, inferiores y próximas.
La vista de biblioteca es para la navegación de referencia. Use el comprobador cuando quiera ejecutar otro código como acción.
30productos farmacéuticosout3002human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excl. yeasts) and similar productsout300210antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processesout30021010antisera(2012-2016);antisera(2002-2011);antisera(1988-2001)out30021095blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of human blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(2012-2012);blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of human blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(2002-2011);blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of human blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(1988-2001)out30021098blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes (excl. antisera, haemoglobin, blood globulins and serum globulins)out30021099blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of animal blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(2012-2012);blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of animal blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(2002-2011);blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of animal blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(1988-2001)out
Qué significa esto para la preparación.
Esta fila no activa directamente la recogida de pruebas en el resultado de ámbito actual.
Regulation (EU) 2023/1115 Annex I — relevant productsconsultado el 2026-08-06Commission Delegated Regulation (EU) 2026/2102 amending Annex I to Regulation (EU) 2023/1115consultado el 2026-09-24Eurostat Comext Combined Nomenclature codelist (CXT_NC v11.0)consultado el 2026-08-06Eurostat Comext partner country codelist (CXT_FREE_ISO)consultado el 2026-08-06Eurostat Comext DS-045409 — EU trade since 1988 by HS2-4-6 and CN8consultado el 2026-08-06Commission Implementing Regulation (EU) 2025/1093 — country benchmarkingconsultado el 2026-08-06Regulation (EU) 2025/2650 amending Regulation (EU) 2023/1115 as regards certain obligations of operators and tradersconsultado el 2025-12-26Commission Implementing Regulation (EU) 2026/1565 amending Implementing Regulation (EU) 2024/3084 (EUDR information system)consultado el 2026-08-08